Abstract
Since its discovery in 1983, HIV-1 has become the most extensively studied pathogen in history. Massive CD4+ T-cell depletion and sustained immune activation and inflammation are hallmarks of HIV-1 infection. However, many insights underlying the onset of immunodeficiency that develops during HIV-1 infection remain to be resolved. In recent years, an intriguing parallel between HIV-1 infection and aging has emerged: many of the alterations that affect innate and adaptive immune cell compartments in HIV-infected patients are reminiscent of the process of immune aging, characteristic of old age. These alterations, of which the alleged cause is the systemic chronic immune activation established in patients, likely participate to the decline of immune competence with HIV disease progression. Of note, the comparison between HIV-1-infected patients and uninfected elderly adults goes beyond the sole onset of immunosenescence and extends to the deterioration of a number of physiological functions related to inflammation and systemic aging. Our understanding of the precise link between immune activation and aging in HIV-1 infection is complicated by the influence of coinfections and lifestyle factors. Developing rational interventions to reduce the hyper-inflammatory status and age resembling manifestations in HIV-1-infected patients are major goals of the HIV community.
References
Alter G et al (2005) Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106:3366–3369
Alter G et al (2009) HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol 83:6798–6805
Amorosa V, Tebas P (2006) Bone disease and HIV infection. Clin Infect Dis 42:108–114
Ancuta P et al (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3:e2516
Andrew D, Aspinall R (2002) Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 37:455–463
Angin M et al (2016) Preservation of lymphopoietic potential and virus suppressive capacity by CD8+ T cells in HIV-2-infected controllers. J Immunol 197(7):2787–2795
Anzala AO et al (2000) Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 182:459–466
Appay V, van Lier RA, Sallusto F, Roederer M (2008) Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73:975–983
Appay V et al (2011) Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. AIDS 25:1813–1822
Aspinall R, Andrew D (2000) Thymic involution in aging. J Clin Immunol 20:250–256
Azzoni L et al (2002) Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. J Immunol 168:5764–5770
Bastard JP et al (2015) Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity. J Antimicrob Chemother 70:1816–1824
Bayard C et al (2016) Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans. Eur J Immunol 46:1168–1179
Best C et al (2015) Sitagliptin reduces inflammation and chronic immune cell activation in HIV+ adults with impaired glucose tolerance. J Clin Endocrinol Metab 100:2621–2629
Betts MR et al (2001) Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75:11983–11991
Beziat V et al (2013) NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121:2678–2688
Bozzano F et al (2011) NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. Int Immunol 23:109–118
Brenchley JM et al (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101:2711–2720
Brenchley JM et al (2006a) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12:1365–1371
Brenchley JM, Price DA, Douek DC (2006b) HIV disease: fallout from a mucosal catastrophe? Nat Immunol 7:235–239
Briceno O et al (2016) Reduced naive CD8(+) T-cell priming efficacy in elderly adults. Aging Cell 15:14–21
Brunetta E, Hudspeth KL, Mavilio D (2010) Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. J Leukoc Biol 88:1119–1130
Bruunsgaard H, Skinhoj P, Pedersen AN, Schroll M, Pedersen BK (2000) Aging, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol 121:255–260
Bruunsgaard H, Pedersen M, Pedersen BK (2001) Aging and proinflammatory cytokines. Curr Opin Hematol 8:131–136
Byakwaga H et al (2011) Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial. J Infect Dis 204:1532–1540
Campillo-Gimenez L et al (2014) Neutrophils in antiretroviral therapy-controlled HIV demonstrate hyperactivation associated with a specific IL-17/IL-22 environment. J Allergy Clin Immunol 134(5):1142–1152
Clark DR et al (2000) T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy. Blood 96:242–249
Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52:M201–M208
Conti A et al (2007) Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res Rev 54:205–218
Crowe SM et al (2010) The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol 87:589–598
d’Ettorre G et al (2015) Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the “Probio-HIV” clinical trial. PLoS One 10:e0137200
Decrion AZ, Dichamp I, Varin A, Herbein G (2005) HIV and inflammation. Curr HIV Res 3:243–259
Desquilbet L et al (2007) HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 62(11):1279–1286. AIDS In Press
Dion ML et al (2004) HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21:757–768
Doisne JM et al (2004) CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 173:2410–2418
Douek DC et al (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95–98
Dunn HS et al (2002) Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 186:15–22
Effros RB, Pawelec G (1997) Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion? Immunol Today 18:450–454
Effros RB et al (1996) Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10:F17–F22
Erlandson KM, Jiang Y, Debanne SM, McComsey GA (2015) Rosuvastatin worsens insulin resistance in HIV-infected adults on antiretroviral therapy. Clin Infect Dis 61:1566–1572
Erlandson KM, Jiang Y, Debanne SM, McComsey GA (2016) Effects of 96 weeks of rosuvastatin on bone, muscle, and fat in HIV-infected adults on effective antiretroviral therapy. AIDS Res Hum Retrovir 32(4):311–316
Fabre-Mersseman V et al (2014) Vitamin D supplementation is associated with reduced immune activation levels in HIV-1-infected patients on suppressive antiretroviral therapy. AIDS 28:2677–2682
Fauci AS, Mavilio D, Kottilil S (2005) NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 5:835–843
Favre D et al (2011) HIV disease progression correlates with the generation of dysfunctional naive CD8low T cells. Blood 117(7):2189–2199
Ferreira C, Barthlott T, Garcia S, Zamoyska R, Stockinger B (2000) Differential survival of naive CD4 and CD8 T cells. J Immunol 165:3689–3694
Ferrucci L et al (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47:639–646
Foulds KE et al (2002) Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol 168:1528–1532
Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafe M (1999) Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp Gerontol 34:911–921
Fried LP et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
Funderburg NT et al (2015) Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr 68:396–404
Gamadia LE et al (2004) The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol 172:6107–6114
Gautier D, Beq S, Cortesao CS, Sousa AE, Cheynier R (2007) Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection. J Virol 81:12685–12688
George VK et al (2015) HIV infection worsens age-associated defects in antibody responses to influenza vaccine. J Infect Dis 211:1959–1968
Ginaldi L, De Martinis M, Monti D, Franceschi C (2005) Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol 26:79–84
Giorgi JV et al (1993) Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS cohort study. J Acquir Immune Defic Syndr 6:904–912
Giorgi JV et al (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179:859–870
Goodwin SR et al (2013) Dipeptidyl peptidase IV inhibition does not adversely affect immune or virological status in HIV infected men and women: a pilot safety study. J Clin Endocrinol Metab 98:743–751
Gougeon ML, Montagnier L (1993) Apoptosis in AIDS. Science 260:1269–1270
Greenstein BD, Fitzpatrick FT, Kendall MD, Wheeler MJ (1987) Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol 112:345–350
Griffin WS, Mrak RE (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease. J Leukoc Biol 72:233–238
Group I.S.S et al (2015) Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373:795–807
Groux H et al (1992) Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331–340
Guo X et al (2016) The role of HIV-1 in affecting the proliferation ability of HPCs derived from BM. J Acquir Immune Defic Syndr 71:467–473
Gupta SK et al (2013) Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial. PLoS One 8:e60852
Hattab S et al (2014) Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study. BMC Infect Dis 14:122
Hazenberg MD et al (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17:1881–1888
Hearps AC et al (2012a) HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy. AIDS 26:843–853
Hearps AC et al (2012b) Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11:867–875
Henson SM et al (2014) p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells. J Clin Invest 124:4004–4016
Hey-Cunningham WJ et al (2015) Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels. AIDS 29:911–919
Homann D, Teyton L, Oldstone MB (2001) Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 7:913–919
Hsue PY et al (2004) Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109:1603–1608
Hsue PY et al (2006) Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 20:2275–2283
Hunt PW et al (2011) Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 203:1474–1483
Jaworowski A et al (2006) Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients. J Infect Dis 193:693–697
Jing Y et al (2009) Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 70:777–784
Kawakami K, Scheidereit C, Roeder RG (1988) Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc Natl Acad Sci U S A 85:4700–4704
Kelley KW, Arkins S, Minshall C, Liu Q, Dantzer R (1996) Growth hormone, growth factors and hematopoiesis. Horm Res 45:38–45
Kendall MD et al (1990) Reversal of aging changes in the thymus of rats by chemical or surgical castration. Cell Tissue Res 261:555–564
Kovacs JA et al (1996) Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 335:1350–1356
Kyoizumi S et al (2013) Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells. J Immunol 190:6164–6172
Lachmann R et al (2015) A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection. AIDS 29:1127–1135
Lanna A, Henson SM, Escors D, Akbar AN (2014) The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nat Immunol 15:965–972
Lelievre JD et al (2012) Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG–PET/computed tomography. J Acquir Immune Defic Syndr 61:56–63
Levy Y et al (2009) Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 119:997–1007
Liovat AS et al (2012) Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One 7:e46143
Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE (1993) T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585–2594
Markowitz M et al (2014) A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals. J Acquir Immune Defic Syndr 66:140–147
Mavilio D et al (2005) Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 102:2886–2891
Mavilio D et al (2006) Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 203:2339–2350
McArthur JC et al (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS cohort study. Neurology 43:2245–2252
McCann SM et al (1998) The nitric oxide hypothesis of aging. Exp Gerontol 33:813–826
Merrill JE (1992) Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14:1–10
Merrill JE, Koyanagi Y, Chen IS (1989) Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 63:4404–4408
Meyaard L et al (1992) Programmed death of T cells in HIV-1 infection. Science 257:217–219
Moir S, Fauci AS (2014) B-cell exhaustion in HIV infection: the role of immune activation. Curr Opin HIV AIDS 9:472–477
Moir S et al (2001) HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A 98:10362–10367
Moir S et al (2008a) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205:1797–1805
Moir S et al (2008b) Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis 197:572–579
Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JE (1989) Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest 84:733–737
Montoya CJ et al (2012) Randomized clinical trial of lovastatin in HIV-infected, HAART naive patients (NCT00721305). J Infect 65:549–558
Morris L et al (1998) HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 188:233–245
Moses A, Nelson J, Bagby GC Jr (1998) The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91:1479–1495
Nakanjako D et al (2015) Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial. Tropical Med Int Health 20:380–390
Napolitano LA et al (2002) Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 16:1103–1111
Pacanowski J et al (2001) Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98:3016–3021
Papagno L et al (2002) Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol 130:509–517
Papagno L et al (2004) Immune activation and CD8(+) T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2:E20
Parmigiani A et al (2013) Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PLoS One 8:e79816
Paton NI et al (2012) Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial. JAMA 308:353–361
Pensieroso S et al (2013) B-cell subset alterations and correlated factors in HIV-1 infection. AIDS 27:1209–1217
Piconi S et al (2011) Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders. Blood 118:3263–3272
Pommier JP et al (1997) Immunosenescence in HIV pathogenesis. Virology 231:148–154
Redd AD et al (2015) Decreased monocyte activation with daily acyclovir use in HIV-1/HSV-2 coinfected women. Sex Transm Infect 91:485–488
Reeves RK et al (2015) Antigen-specific NK cell memory in rhesus macaques. Nat Immunol 16:927–932
Rieckmann P, Poli G, Fox CH, Kehrl JH, Fauci AS (1991) Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 147:2922–2927
Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA (1995) CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 95:2061–2066
Routy JP et al (2015) Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy. HIV Med 16:48–56
Sauce D et al (2011) HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood 117:5142–5151
Sauce D et al (2012) Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults. J Immunol 189:5541–5548
Schouten J et al (2014) Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 59:1787–1797
Schuetz A et al (2014) Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog 10:e1004543
Scutellari PN, Orzincolo C, Guarnelli EM (1996) Periodontal disease in patients with HIV infection. Radiographic study. Radiol Med (Torino) 92:562–568
Silvestri G et al (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18:441–452
Simmons A, Aluvihare V, McMichael A (2001) Nef triggers a transcriptional program in T cells imitating single- signal T cell activation and inducing HIV virulence mediators. Immunity 14:763–777
Solana R, Campos C, Pera A, Tarazona R (2014) Shaping of NK cell subsets by aging. Curr Opin Immunol 29:56–61
Soumelis V et al (2001) Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98:906–912
Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169:3400–3406
Stockmann M et al (2000) Mechanisms of epithelial barrier impairment in HIV infection. Ann N Y Acad Sci 915:293–303
Swingler S et al (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 5:997–103
Tenorio AR et al (2015) Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy – ACTG A5286. J Infect Dis 211:780–790
Valcour VG, Shikuma CM, Watters MR, Sacktor NC (2004) Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 18(Suppl 1):S79–S86
van Lelyveld SF et al (2015) Maraviroc intensification of cART in patients with suboptimal immunological recovery: a 48-week, placebo-controlled randomized trial. PLoS One 10:e0132430
Vesterbacka J, Barqasho B, Haggblom A, Nowak P (2015) Effects of co-trimoxazole on microbial translocation in HIV-1 infected patients initiating antiretroviral therapy. AIDS Res Hum Retrovir 31:830–836
Villinger F et al (2001) Chronic immune stimulation accelerates SIV-induced disease progression. J Med Primatol 30:254–259
Wallace DL et al (2006) Prolonged exposure of naive CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 119:243–253
Wallet MA et al (2015) Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects. BMC Immunol 16:43
Weaver JD et al (2002) Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 59:371–378
Weiss L, Haeffner-Cavaillon N, Laude M, Gilquin J, Kazatchkine MD (1989) HIV infection is associated with the spontaneous production of interleukin-1 (IL-1) in vivo and with an abnormal release of IL-1 alpha in vitro. AIDS 3:695–699
Wittkop L et al (2013) Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. J Infect Dis 207:622–627
Wolthers KC et al (1996) T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274:1543–1547
Yang OO, Kelesidis T, Cordova R, Khanlou H (2014) Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res Hum Retrovir 30:988–995
Yi TJ et al (2013) A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy. Clin Infect Dis 57:1331–1338
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Appay, V., Sauce, D., Kelleher, A.D. (2018). HIV Infection as a Model of Accelerated Immunosenescence. In: Fulop, T., Franceschi, C., Hirokawa, K., Pawelec, G. (eds) Handbook of Immunosenescence. Springer, Cham. https://doi.org/10.1007/978-3-319-64597-1_50-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-64597-1_50-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64597-1
Online ISBN: 978-3-319-64597-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences